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ABSTRACT – Background. Epilepsy is associated with ictal autonomic dysfunc-
tion which may extend into the inter-ictal period. Antiepileptic drugs have often
been blamed for cardiac autonomic dysfunction in epilepsy patients. In this
study we have investigated cardiac autonomic parameters in order to evaluate
autonomic functions of drug-naïve epilepsy patients. Method. Twenty drug-
naïve patients (15 males and 5 females) with epilepsy, and an equal number of
age and gender matched controls, were evaluated for short-term resting heart
rate variability and conventional cardiovascular autonomic measurements.
Results. The mean age of patients was 29.30 ± 9.80 yrs (17-55 yrs), mean age
at seizure onset was 19.70 ± 9.15 yrs (3-40 yrs) and mean length of time since
last seizure was 5.60 ± 7.00 days (1-30 days). While there was no difference in
the resting heart rate or conventional autonomic test parameters, time
domain heart rate variability measurements showed a decreased percentage
of R-R intervals of less than 50 ms and root mean square of R-R intervals
in patients, when compared to controls. Frequency domain parameters
showed a decreased total power (patients: 1,796.58 ± 1,052.45 ms2; controls:
2,934.23 ± 1,767.06 ms2, p = 0.008). Parameters indicative of decreased vagal
tone, i.e. decreased high frequency power and increased low to high frequency
ratio (patients: 1.69 ± 0.94; controls: 1.14 ± 0.64, p = 0.045), were observed
among patients compared to controls. Conclusion. Subtle but definite cardiac
autonomic dysfunction, especially in vagal tone, was identified in drug-naïve,
new-onset epilepsy patients. Seizures can cause long-term and often progres-
sive cardiac autonomic dysfunction which may be independent of concomitant
antiepileptic drugs.
Key words: autonomic function tests, heart rate variability, drug-naïve, newly
diagnosed epilepsy, SUDEP
Activation of the autonomic nervous
system has been well documented in
patients receiving electroconvulsive
therapy (ECT) and in those with spon-
taneous symptomatic seizures during
ictus (Brown et al., 1953; Van Buren,
1958). Autonomic dysfunction has
also been noted to extend well into the
inter-ictal period and could be the
only sign during this phase of clinical
calm. Several studies have shown that
the clinical hallmark of seizure onset
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is a decreased variability in the heart rate and decreased
sympathetic tone resulting from autonomic activation
(Nashef et al., 1996; Novak et al., 1999; Lai et al., 2008).
Autonomic dysfunction is more prominent in patients with
refractory epilepsy as well as in long-standing and well
controlled epilepsy. Possible mechanisms for this dysfunc-
tion include uncontrolled electrical stimulation and/or
chronic functional changes in the related neuro-
anatomical regions of the brain (Ansakorpi et al., 2002).
We have previously demonstrated a significant inter-ictal
autonomic dysfunction in patients with refractory epilepsy
(Sathyaprabha et al., 2006).
Sudden unexplained death in epilepsy (SUDEP) remains an
important cause of mortality in refractory epilepsy (Nashef
et al., 1996). Although the exact mechanisms of SUDEP are
presently unclear, autonomic dysfunction is said to play a
significant role. Diehl and colleagues demonstrated an
inter-ictal increase in the sympathetic modulation of cere-
bral blood flow velocities in epilepsy patients (Diehl et al.,
1997). Inter-ictal spikes seen in an electroencephalograph
(EEG) might also suggest subclinical electrical seizures and
thus ongoing autonomic activation. Autonomic dysfunction
in epilepsy was previously attributed partly to the use and
withdrawal of anticonvulsants, especially carbamazepine
(Hennessy et al., 2001). Administration of this drug has
been shown to decrease heart rate variability and cause
parasympathetic hypofunction. Studies by our group
(Sathyaprabha et al., 2006) and Berilgen et al. (2004) have
shown no significant association between autonomic
dysfunction and the use of anticonvulsants. Berilgen et al.
(2004) have also suggested that autonomic changes are
amenable to antiepileptic medication.
It has remained unclear, however, whether autonomic
dysfunction evolves in new-onset, drug-naïve, epilepsy
patients. One previous study evaluating cardiac autonomic
parameters in drug-naïve patients using conventional auto-
nomic tests did not show any dysfunction (Isojärvi et al.,
1998). Functional imaging studies in drug-naïve epilepsy
patients have shown abnormal inter-ictal regional cortical
blood flow in areas responsible for autonomic modulation
(Joo et al., 2008). We undertook this study of drug-naïve,
newly diagnosed epilepsy patients to investigate whether
epilepsy per se causes cardiovascular autonomic dysfunc-
tion and whether this dysfunction occurs at very early stages
in the disease process. As well as conventional autonomic
tests, sensitive techniques such as spectral changes in heart
rate variability were used to assess cardiac autonomic
function.
Patients and methods
This study was carried out at a university teaching
hospital, a leading tertiary neuropsychiatric referral
centre in Southern India. This study was approved by
the institute ethical committee and written informed
consent was obtained from each subject. Adult patients
with untreated and newly diagnosed epilepsy were
individually inducted into the study. Clinical seizure
semiology and frequency were noted for each patient
and inter-ictal EEG was performed to corroborate
clinical diagnosis. Computerised tomography (CT) or
magnetic resonance imaging (MRI) was performed for
all patients to determine structural pathology. Patients
who were clinically diagnosed as having idiopathic
generalised tonic-clonic epilepsy with normal imaging
(CT/MRI) were subjected to autonomic function tests.
Patients who had a seizure during the previous 24-hour
period were excluded. Age and gender matched healthy
controls were chosen from amongst relatives of patients
and hospital staff. Subjects with diabetes mellitus,
endocrinological disorders, cardiopulmonary diseases,
Parkinson’s disease or a history of substance abuse were
excluded. Patients with structural abnormalities based on
imaging were also excluded. Female subjects who were
either pregnant or lactating were also excluded from
the study.
Cardiovascular autonomic function tests
The patients were subjected to a battery of standardised
Autonomic Function Tests (AFT) for the assessment of
cardiac autonomic functions. For female subjects, the
autonomic tests were done during the proliferative
phase of their menstrual cycle. Electrocardiogram and
blood pressure were recorded during normal breathing
and after rest in supine position for 30 min.
The ECG signal was acquired digitally at 256 samples per
second. Consecutive RR intervals, defined as the time
elapsing between two consecutive R waves in the electro-
cardiogram measured from the ECG for a period of 1 min,
and standard deviation (SD) of the intervals were used
as baseline variables. The procedure has been described
in detail in previous publications (Sathyaprabha et al.,
2006, 2008).
The autonomic parameters measured included:
– heart rate (HR) parameters:
• deep breathing ratio (beats/min),
• Valsalva ratio,
• min:max ratio;
– blood pressure (BP) measurements:
• isometric ΔDBP (mmHg),
• standing ΔSBP (mmHg).
Heart rate variability
A five-minute error-free Lead II electrocardiogram was
recorded for all individuals at rest and supine position
under standard conditions. The raw ECG was converted
into consecutive R-R intervals for analysis. Analysis
was performed using HRV Analysis Software V1.1
(Biomedical Signal Analysis Group, Department of
Applied Physics, University of Kuopio, Finland).
Autonomic functions in epilepsy
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The following parameters were chosen as per the recom-
mendations of the European Society of Cardiology, 1996
(Camm and Malik, 1996).
– Time domain parameters:
• heart rate (beats/min),
• mean RR interval (ms),
• mean standard deviation of successive R-R intervals
(RRSD) (ms),
• root mean square (square root of the mean squared)
successive difference of intervals (RMSSD) (ms),
• number of interval differences of successive RR
intervals greater than 50 ms (NN50). NN50 divided
by the total number of NN intervals (pNN50).
– Spectral analysis for frequency domain parameters
was performed using parametric spectrum analysis
(auto-regressive modelling). The following parameters
were measured:
• total power (TOTP) (ms2),
• very low frequency absolute power (VLFP) (ms2),
• low frequency absolute power (LFP) (ms2),
• high frequency absolute power (HFP) (ms2),
• low frequency absolute power expressed in
normalised units (LFnu) (ms2),
• high frequency absolute power expressed in
normalised units (HFnu) (ms2),
• LF/HF ratio.
Statistical analysis
All continuous variables were expressed as mean ±
standard deviation. Comparison between patients and
controls was carried out using the Mann-Whitney U test.
Significance was set at p < 0.05.
Results
Of the 20 patients, none had a history of status epilepticus
or concurrent drug use for other ailments. Imaging studies
showed that these patients did not have any structural
abnormalities. Demographic details of patients and
healthy controls are given in table 1. The mean age of
patients was 29.3 ± 9.8 yrs (17-55 yrs), mean age at sei-
zure onset was 19.7 ± 9.2 yrs (3-40 yrs) and mean length
of time since last seizure was 5.6 ± 7.0 days (1-30 days).
The comparison of conventional cardiovascular reflex
tests is presented in table 2. There was no statistically
significant difference in conventional autonomic test
parameters between patients and controls. The heart rate
variability measurements from both groups are presented
in table 3. Time domain heart rate variability measure-
ments showed a significant decreased percentage of
R-R intervals less than 50 ms and root mean square of
R-R intervals in patients, when compared to controls.
Frequency domain parameters showed decreased total
and high frequency power in patients when compared to
controls. Patients also had an increased low to high fre-
quency ratio. When expressed in normalised units,
patients demonstrated an increase in low frequency
power and a trend towards a decrease in high frequency
power.
Discussion
The patients’ demographic data shows that while the
mean age of patients was 29.30 years, the mean age at
seizure onset was 19.70 years. This is unusual given that
Table 1. Demographic data.
Patients (n = 20) Controls (n = 20)
Age (years) 29.3 ± 9.8 (17-55) 28.8 ± 6.2 (20-44)
Sex (M:F) 15:5 15:5
Age at onset (years) 19.7 ± 9.2 (3-40) NA
Duration of illness (months) 52.8 ± 70.1 (0.7-182.5) NA
Seizure frequency (days)* 334.1 ± 609.4 (0-2185) NA
Seizure free interval (days) 5.6 ± 6.99 (1-30) NA
* Interval between first and second seizure; NA: not applicable.
Table 2. Conventional autonomic function tests.
Autonomic function test Patients (n = 20) Controls (n = 20) P
Deep breathing ratio 22.95 ± 10.03 22.41 ± 6.43 0.657
Valsalva ratio 1.63 ± 0.33 1.45 ± 0.18 0.347
Max:min ratio 1.37 ± 0.19 1.38 ± 0.18 0.754
Isometric hand grip ΔDBP (mm Hg) 8.70 ± 5.59 11.45 ± 5.09 0.094
Standing ΔSBP (mm Hg) 6.20 ± 3.35 5.50 ± 1.79 0.415
SBP: systolic blood pressure; DBP: diastolic blood pressure.
P. Mativo, et al.
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a previous study has shown that the average delay
from diagnosis to treatment in urban India was about
1.5 ± 4 years (Thomas, 2001). Our population was derived
predominantly from rural India and socio-cultural
practices may have lead to the longer delay in obtaining
treatment. In most cases the age at seizure onset was a
retrospective estimate based on clinical history. Patients
might have avoided allopathic medical treatment since
early episodes may have been unrecognised by care-
givers. Duration of untreated epilepsy varies greatly even
in western cohorts; in the study of Persson et al. (2007)
four of 22 subjects experienced seizures without treat-
ment for 10 years or more and nine for a period of
one year or more. In order to take into account the large
variation of duration of illness prior to diagnosis, we
calculated seizure frequency as the duration between
the first and second seizure. The 24-hour gap between
the last seizure and autonomic tests excluded behavioural
and post-ictal autonomic influences. The predominately
male representation of our cohort was also probably due
to prevailing socio-cultural factors.
Standardised autonomic tests did not reveal any differ-
ences between patients and controls. This finding is
similar to that of a previous study by Isojärvi et al. (1998)
who concluded that inter-ictal autonomic nervous system
function in patients with untreated epilepsy was not
significantly different from that of healthy control subjects,
based on standardised cardiovascular reflex tests.
However, in this study, heart rate variability parameters,
which are more sensitive indicators, demonstrated a
significant difference between patients and control
subjects. Time domain parameters RMSSD and pNN50
correspond approximately to HFP which is considered to
be a measure of vagal tone. This is based on the presump-
tion that vagal (neural) modulation of HRV occurs at a
faster rate than sympathetic (vascular) modulation
(Camm and Malik, 1996). Using both time domain and
frequency domain parameters, subtle cardiac autonomic
dysfunction, especially in the vagal tone in drug-naïve,
new-onset epilepsy patients, was identified. A previous
study of HRV in newly diagnosed military recruits with
epilepsy reported reduced HF, increased LF and an
increased LF/HF ratio (Evrengül et al., 2005). These find-
ings were replicated in our study with frequency domain
parameters showing decreased total power and high
frequency power in patients when compared to controls.
Patients also demonstrated an increased high frequency to
low frequency ratio. When expressed in normalised units,
patients demonstrated an increase in low frequency
power and a trend towards decrease in high frequency
power. Time domain heart rate variability measurements
showed a decreased percentage of R-R intervals less than
50 ms and root mean square of R-R intervals in patients,
when compared to controls.
In the similar study of Persson et al. (2007) no HRV abnor-
malities were identified in a cohort of 22 drug-naïve
patients. This series consisted of patients with both
complex partial seizures and generalised tonic-clonic
seizures. While the dissimilar inclusion criteria may have
contributed to the difference in findings between our
study and that of Persson et al. (2007), the longer duration
of unrecognised and thus untreated seizures in our study
may also have contributed.
Activation of the autonomic nervous system is a well
known ictal phenomenon in patients with epilepsy. This
activation is known to extend well into the inter-ictal
phase. Numerous studies have shown decreased heart
rate variability and decreased sympathetic tone caused
by autonomic activation (Nashef et al., 1996; Novak
et al., 1999; Lai et al., 2008). Almost all patients with
Table 3. Time domain and frequency domain analysis of heart rate variability.
Parameter Patients (n = 20) Controls (n = 20) P
Mean heart rate (beats/min) 75.93 ± 13.08 74.4 ± 8.2 0.375
RRSD (ms) 49.99 ± 25.49 39.7 ± 8.4 0.076
RMSSD (ms) 30.32 ± 9.67 35.0 ± 13.7 0.001
NN50 109.35 ± 172.79 47.4 ± 49.2 0.657
pNN50 9.77 ± 8.95 13.9 ± 14.3 < 0.001
TOTP (ms2) 1,796.58 ± 1,052.45 2,934.23 ± 1,767.06 0.008
LFP (ms2) 579.75 ± 418.99 863.62 ± 638.45 0.054
HFP (ms2) 396.05 ± 248.61 935.54 ± 966.10 0.001
LFnu (ms2) 55.04 ± 13.55 46.35 ± 12.79 0.045
HFnu (ms2) 39.05 ± 12.94 46.95 ± 12.63 0.064
LF/HF 1.69 ± 0.94 1.14 ± 0.64 0.045
RRSD: standard deviation of R-R interval; RMSSD: root mean square successive difference of intervals; NN50: number of interval
differences of successive RR intervals greater than 50 ms; pNN50: percentage of NN50; TOTP: total power; VLFP: very low frequency
absolute power; LFP: low frequency absolute power; HFP: high frequency absolute power; LFnu: low frequency absolute power in
normalised units; HFnu: high frequency absolute power in normalised units; LF/HF: low frequency to high frequency ratio.
Autonomic functions in epilepsy
Epileptic Disord Vol. 12, No. 3, September 2010 215
Co
py
rig
ht
 ©
 2
01
8 
Jo
hn
 L
ib
be
y 
Eu
ro
te
xt
. D
ow
nl
oa
de
d 
by
 M
on
sie
ur
 A
LE
XI
S 
AR
ZI
M
AN
O
G
LO
U 
on
 1
1/
09
/2
01
8.
generalised tonic-clonic seizures have ictal autonomic
changes and a third with partial seizures also develop
autonomic dysfunction (Nouri and Balish, 2008).
Seizures can cause long-term and often progressive
cardiac autonomic dysfunction (Ansakorpi et al.; 2002,
Sathyaprabha et al., 2006). Autonomic dysfunction is
more prominent in patients with refractory epilepsy and
could be caused by uncontrolled electrical stimulation
and chronic functional changes in the related neuroana-
tomical regions of the brain. SUDEP remains an impor-
tant cause of mortality in refractory epilepsy. Several
mechanisms for SUDEP have been proposed. Of these,
parasympathetic dysfunction, leading to central apnoea,
arrhythmias and cardiac failure is believed to play a
crucial role (Nashef et al., 1996). While the link between
antiepileptic medication and autonomic dysfunction
remains controversial, especially with regards to carba-
mazepine, Berilgen et al. (2004) have suggested that
autonomic changes are amenable to antiepileptic
medication and future studies should be aimed at demon-
strating normalisation of cardiac parameters of patients
with specific antiepileptic treatment. Hence, early assess-
ment of autonomic dysfunction and further preventive
strategies may be useful to avoid cases of SUDEP.
Conclusion
In this study we sought to investigate the presence of
cardiovascular autonomic dysfunction using sensitive
measurements, such as heart rate variability, in drug-
naïve epilepsy patients with idiopathic generalised tonic-
clonic epilepsy. Subtle cardiac autonomic dysfunction,
especially in vagal tone, was identified in these patients.
Since seizures are already known to cause long-term and
often progressive cardiac autonomic dysfunction, early,
comprehensive and aggressive management of epilepsy
may stabilise any dysfunction and help prevent SUDEP.
Future research should require longitudinal studies using
larger cohorts of newly diagnosed, drug-naïve epileptic
patients. □
Disclosure.
None of the authors has any conflict of interest or financial support to
disclose.
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